Dr. Brownell has spent the last 35 years in the bio/pharmaceutical arena where she has played key roles in Discovery, Development and Opportunity Assessment to drive innovation.
After completing her doctorate, Elise’s career started at SUNY Stony Brook where she made discoveries relating to genetic evolution in the great apes. She continued her interest in comparative molecular biology during her tenure at Frederick Cancer Research Facility and expanded her facility with molecular genetics while in various functions at Bayer Healthcare. She played a pivotal role in directing discovery research in the areas of asthma, allergy, and immunology and continued her dedication to innovation by managing extramural collaborations for Bayer’s Biotechnology unit. Her efforts were widely recognized by promotion to Director, Project Management, where she led global cross-functional teams to bring several of Bayer’s biopharmaceuticals from bench to clinic. She was a member of the founding team of a venture-backed Bayer spin out (Aerovance, Inc), where she became head of project management. During her tenure as Senior Director, Aerovance garnered over $ 60 MUSD, completed six clinical trials in 3.5 years, and built a right-sized matrixed organization.
In 2008, she co-founded ZephyrBiotech, LLC, a consulting practice that provides project leadership, management and planning to entrepreneurial life science companies, especially those that are early-stage, venture-backed entities. Her experience within the investment community has been strengthened by her tenure with The Angels’ Forum (Mountain View, CA), where she was responsible for managing all incoming deal flow and presentation preparation.
Currently, Dr. Brownell serves as Executive Vice President of Operations and Project Management at Amarantus Bioscience Holdings, Inc. where she oversees all development programs across a diverse therapeutics portfolio.« Back to Management Team